# No ‘Next Day’ Impairment Caused by Cannabis – The Leaf Online > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/no-next-day-cannabis-impairment-clinical-insights/ > **Published:** 2026-03-18T21:11:09-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T11:05:41-04:00 > **Clinical Summary:** Explore clinical insights on no next day cannabis impairment and its impact on daytime function and safety in 2026 research findings. --- ✦ New CED Clinical Relevance #72 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ResearchSafetyAging Dr. Caplan’s Take “What this research tells us clinically is that we can now counsel patients more precisely about cannabis timing and safety, particularly those concerned about impairment affecting their daytime function or work performance, which has been a legitimate barrier to treatment adherence for many people I see.” Clinical Perspective While this article highlights a study suggesting no next-day [cognitive impairment](https://cedclinic.com/acute-effects-partial-cb1-receptor-agonists-cognition/) from [cannabis use](https://cedclinic.com/cannabis-cardiovascular-health-insights-2024/), clinicians should interpret this finding with appropriate caution given the limited information available and the heterogeneity of cannabis products, dosing regimens, and individual user factors that influence pharmacokinetics and sensitivity. The evidence base for cannabis effects on next-day functioning remains relatively sparse compared to well-established substances like alcohol, and individual variation in [cannabinoid metabolism](https://cedclinic.com/fatty-acid-amide-hydrolase-obesity-risk-genetic-links/), frequency of use, and baseline cognitive status may substantially modify risk profiles across different patients. Important confounders such as sleep quality, concurrent medications, underlying sleep disorders, and the specific cannabinoid profile and potency of products used were likely not uniformly controlled across users. In clinical encounters, practitioners should continue to counsel patients that cannabis impairment timing and duration are incompletely characterized, recommend avoiding safety-sensitive activities until individual response is better understood, and assess each patient’s unique risk factors rather than 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/forum/cannabis-related-research/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just+read+this+on+CEDclinic.com%3A+No+%27next+day%27+impairment+caused+by+cannabis+-+The+Leaf+Online+%40drcaplan&url=https%3A%2F%2Ftheleafonline.com%2Fc%2Fscience%2F2026%2F03%2Fnext-day-driving-2026%2F)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Ftheleafonline.com%2Fc%2Fscience%2F2026%2F03%2Fnext-day-driving-2026%2F)[🦅 Share on BlueSky](https://bsky.app/intent/compose?text=Just+read+this%3A+No+%27next+day%27+impairment+caused+by+cannabis+-+The+Leaf+Online+--+via+%40drcaplan.bsky.social+https%3A%2F%2Ftheleafonline.com%2Fc%2Fscience%2F2026%2F03%2Fnext-day-driving-2026%2F)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) Related Articles - No ‘next day’ impairment caused by cannabis – The Leaf Online - [CED Digest: 436 Items — March 14, 2026](https://cedclinic.com/cannabis-compounds-fatty-liver-disease-2026/) - [CED Digest: 405 Items — March 12, 2026](https://cedclinic.com/alabama-medical-cannabis-sales-2026-spring-launch/) 📰 Source: [https://theleafonline.com/c/science/2026/03/next-day-driving-2026/](https://theleafonline.com/c/science/2026/03/next-day-driving-2026/) Further Reading Evidence WatchIGC Pharma Adds Visionary Investigators Network as Clinical Site to Phase 2 CALMA Trial Evidence Watch[Cannabinoid Clinical Trials: CBD & Cortical Excitability](https://cedclinic.com/cbd-anti-seizure-properties-cortical-excitability-trial/) Research Digest[PM News Update: March 17, 2026](https://cedclinic.com/texas-hemp-stricter-thc-rules-march-31-2026/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [Cannabis Medical Benefits and Risks: What Research Says About Its Health Effects](https://cedclinic.com/cannabis-dosing-protocols-safe-therapeutic-use/) A comprehensive review of the medical benefits and risks associated with cannabis use, providing balanced insights for clinical practice. [Read More](https://cedclinic.com/cannabis-dosing-protocols-safe-therapeutic-use/) [Cannabis may be beneficial for the brain at an older age | The Jerusalem Post](https://cedclinic.com/cannabis-neuroprotective-benefits-older-adults/) Explores emerging research on the potential cognitive benefits of cannabis use in older adults and its implications for aging populations. [Explore Article](https://cedclinic.com/cannabis-neuroprotective-benefits-older-adults/) [Adults With Local Access to Cannabis Retailers Are Less Likely To Engage in Heavy Alcohol Use](https://cedclinic.com/cannabis-access-alcohol-use-patterns-heavy-drinking/) Investigates the relationship between cannabis accessibility and alcohol consumption patterns among adults, highlighting [public health](https://cedclinic.com/cannabis-mold-contamination-risks-recall-safety/) considerations. [Learn More](https://cedclinic.com/cannabis-access-alcohol-use-patterns-heavy-drinking/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).